Integrated Cancer Repository for Cancer Research
University of Nebraska
999,999 participants
Nov 1, 2013
OBSERVATIONAL
Conditions
Summary
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.
Eligibility
Inclusion Criteria6
- Diagnosis/history of cancer
- Risk for developing cancer or suspicious clinical findings
- No history of cancer (normal control registry)
- Able to provide informed consent
- years of age or older
- English or Spanish speaking individuals
Exclusion Criteria2
- Unable to provide informed consent because of cognitive impairment
- Non-English or non-Spanish speaking individuals
Locations(45)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02012699